You’ve Just Been Diagnosed With Type 2: Five Things to Keep in Mind

By Patrick Totty You’ve just been diagnosed with type 2 diabetes. It doesn’t matter whether your doctor looked you in the eyes with a kindly gaze when he dropped the bomb, or she just told you straight with no preliminaries: “you have diabetes.” If you’re feeling shell-shocked right now, it’s a perfectly normal reaction to news that has just turned your life upside down. Not

Read more

Life With Type 2: The Power of Naming

This is not a religious essay, so please don’t take the example below wrong. In Genesis, after God creates Adam, he tells him to go about naming the things that God has created-the animals, plants, and landscapes of the newly made world. Adam runs off, pleased to do God’s bidding, naming stuff right and left.Whether you believe in the creation story told by Genesis or

Read more

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea. The drug, already available in Europe, is produced by Bristol-Myers and AstraZeneca. It has been shown to improve blood sugar levels, help reduce body weight, and lead to lower A1c levels when used in tandem with the two other diabetes drugs. The

Read more

Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study

BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical trial to evaluate the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication. The University of Maryland Medical Center and the Baltimore VA Medical Center, which are affiliated with the University of Maryland School of

Read more

A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes

Combination therapy, in which doctors prescribe more than one drug to treat type 2 diabetes, is a fairly common practice. However, most newly diagnosed type 2 patients start off with metformin or a sulfonylurea and don’t go on a two-drug therapy until their first drug begins to lose its effectiveness.

But combination therapy could soon become an earlier option for people with type 2. Merck reports

Read more